Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

Skillz Shares Surge 18% on $420M Papaya Ruling Hope
Markets Daniel Marsh

Skillz Shares Surge 18% on $420M Papaya Ruling Hope

Skillz shares rose 18.2% to $7.80 amid anticipation of a June court ruling on a $420 million false advertising verdict against Papaya Gaming.

SKLZ
Kraken Robotics Rises as Market Eyes Covelya Deal and Defense Orders
Markets Daniel Marsh

Kraken Robotics Rises as Market Eyes Covelya Deal and Defense Orders

Kraken Robotics shares rose 2.2% to C$7.44 Tuesday, bucking a broader market decline, as investors priced in the Covelya deal and defense contracts.

SPY
AMD Shares Fall Ahead of Nvidia Earnings as Yields Rise
Markets Daniel Marsh

AMD Shares Fall Ahead of Nvidia Earnings as Yields Rise

AMD shares dropped 1.6% as investors trimmed chip holdings before Nvidia's earnings and rising yields pressured tech stocks. Citi hiked its AMD price target to $460.

AMD NVDA INTC
Wall Street Slips as Bond Yields Surge to 2025 Highs
Markets Daniel Marsh

Wall Street Slips as Bond Yields Surge to 2025 Highs

U.S. stocks declined Tuesday as the 10-year Treasury yield climbed to its highest since January 2025, pressuring equities. The Dow fell 0.65%, with the S&P 500 and Nasdaq also lower.

NVDA HD DIA SPY QQQ USO GLD
Bond Yield Surge Rattles Wall Street, Nvidia Earnings in Focus
Markets Daniel Marsh

Bond Yield Surge Rattles Wall Street, Nvidia Earnings in Focus

U.S. stocks declined Tuesday as rising Treasury yields and elevated oil prices reignited inflation concerns. Nvidia's earnings and Home Depot's results were key market drivers.

NVDA HD AKAM LOW TGT WMT
Blue Bird Shares Slide 9.6% on Pension Settlement Charge
Markets Daniel Marsh

Blue Bird Shares Slide 9.6% on Pension Settlement Charge

Blue Bird Corp. shares dropped 9.6% to $65.75 following an SEC filing that revealed a material non-cash pension settlement charge for the fiscal third quarter.

BLBD SPY IWM
Thunderstorms Ground Over 350 Flights at American Airlines' DFW Hub
Markets Daniel Marsh

Thunderstorms Ground Over 350 Flights at American Airlines' DFW Hub

Severe storms at Dallas-Fort Worth International Airport led to an FAA ground stop, resulting in 359 flight cancellations and 452 delays, impacting American Airlines' primary hub and nationwide travel.

AAL LUV
Enbridge Shares Hit New High Despite Line 5 Permit Hurdle
Markets Daniel Marsh

Enbridge Shares Hit New High Despite Line 5 Permit Hurdle

Enbridge shares climbed to a 52-week high on Tuesday, advancing 2.76% to C$78.25, as investors focused on reaffirmed 2026 guidance and overlooked a partial construction halt on the Line 5 pipeline in Wisconsin.

ENB PBA META
Amazon Shares Slip as $200B AI Spending Spree Raises Investor Concerns
Markets Daniel Marsh

Amazon Shares Slip as $200B AI Spending Spree Raises Investor Concerns

Amazon shares fell 2.3% on Tuesday as heavy AI spending weighs on free cash flow, despite AWS revenue surging 28% to $37.6 billion. Analysts remain positive but caution on capital expenditure.

AMZN NVDA GOOGL MSFT
Yield Surge Reshapes Stock Picks: Nvidia, Dell, ServiceNow, Home Depot in Focus
Markets Daniel Marsh

Yield Surge Reshapes Stock Picks: Nvidia, Dell, ServiceNow, Home Depot in Focus

U.S. stocks declined Tuesday as the 10-year Treasury yield reached its highest since January 2025, pressuring growth shares. Selective buying focused on Nvidia, Dell, ServiceNow, and Home Depot.

NVDA DELL NOW HD SPY QQQ TLT XLK
Kroger Stock Climbs as CEO Focuses on Price Strategy
Markets Daniel Marsh

Kroger Stock Climbs as CEO Focuses on Price Strategy

Kroger shares gained 3.8% in midday trading Tuesday, outpacing Walmart and Costco, as investors focus on new CEO Greg Foran's pricing strategy.

KR WMT COST AMZN
Co-Diagnostics Stock Skyrockets on Ebola Test Strategy, But Financial Concerns Loom
Markets Daniel Marsh

Co-Diagnostics Stock Skyrockets on Ebola Test Strategy, But Financial Concerns Loom

Co-Diagnostics shares jumped 51% on news of an Ebola assay strategy, but the test awaits regulatory approval and the company faces financial stability concerns.